上市公司不能沦为大股东提款机

Group 1 - Beijing Stock Exchange has imposed disciplinary actions on Yunnan Biovalley Pharmaceutical Co., Ltd. for fund occupation and failure to disclose significant matters, marking the first disciplinary action against a listed company by the exchange [1] - From August 2021 to March 2022, the controlling shareholder, Shenzhen Jinsha River Investment Co., Ltd., occupied a total of 356 million yuan of company funds through endorsements of bank acceptance bills and entrusted third-party financial management, with a maximum daily occupation balance of 277 million yuan [1] - The disciplinary actions included public reprimands for the controlling shareholder and the actual controller, as well as criticism for the company's former financial director and board secretary, and the two sponsoring representatives from Huaron Securities [1] Group 2 - The failure of the sponsoring institutions to effectively supervise the company’s information disclosure system and timely report significant matters to the exchange has been highlighted, emphasizing the need for improved responsibilities of intermediary institutions [2] - The comprehensive registration system reform requires a fair entry system and improved information disclosure system, raising the standards for securities intermediary institutions to fulfill their responsibilities [2] - The controlling shareholders of listed companies are reminded to adhere to laws and regulations, avoid abusing their rights, and not to harm the interests of the company and other shareholders [3] Group 3 - Regulatory authorities are urged to strengthen self-regulation and enforce market discipline, ensuring that controlling shareholders are deterred from misappropriating company funds [3] - The need for securities intermediary institutions to enhance their independence, professionalism, and ethical standards is emphasized to prevent collusion in fraudulent activities [2][3]